Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

First patient dosed in phase I/II study of PhageBank in urinary tract infections

June 4, 2021

U.K. study identifies another danger of COVID-19: increased antibiotic resistance

June 3, 2021

Centivax enters strategic partnership with NMRC for phase I development of Centi-B9

June 3, 2021

NIH announces first-in-human study of FluMos-v1 universal influenza vaccine

June 2, 2021

Novel inhalable liposome formulations of antiviral drugs against COVID-19

June 2, 2021

FDA clears IND for investigational microbiome therapeutic SER-155

June 2, 2021

CARB-X supports BioVersys' development of pyrrolocytosines targeting antibiotic-resistant bacteria

June 1, 2021

Preclinical data show antiviral and anti-inflammatory activity of balixafortide in COVID-19

June 1, 2021

EC-11770 shows broad-spectrum activity in nontuberculous mycobacterial infection models

June 1, 2021

Affibody describes new compounds for HMGB1-related disorders

May 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...